Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 23512198
Zhao J, et al. (2013) SCF E3 ligase F-box protein complex SCF(FBXL19) regulates cell migration by mediating Rac1 ubiquitination and degradation. FASEB J 27, 2611-9 23512198
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S71-p - RAC1 (human)
Modsite: yDRLRPLsYPQTDVF SwissProt Entrez-Gene
Orthologous residues
RAC1 (human): S71‑p, RAC1 iso2 (human): S71‑p, RAC1 (mouse): S71‑p, RAC1 (rat): S71‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Relevant cell lines - cell types - tissues:  MLE12 (epithelial)
Cellular systems studied:  cell lines
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
Akt1 (human) increase
Downstream Regulation
Effect of modification (function):  protein degradation
Comments:  Akt induces Rac1 degradation via S71 phosphorylation

K166-ub - RAC1 (human)
Modsite: ALtQrGLktVFDEAI SwissProt Entrez-Gene
Orthologous residues
RAC1 (human): K166‑ub, RAC1 iso2 (human): K185‑ub, RAC1 (mouse): K166‑ub, RAC1 (rat): K166‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Relevant cell lines - cell types - tissues:  MLE12 (epithelial)
Cellular systems studied:  cell lines
Species studied:  mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
UBIQUITIN LIGASE FBXL19 (human) co-immunoprecipitation, siRNA inhibition of enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
Akt1 (human) increase
Downstream Regulation
Effect of modification (function):  protein degradation
Effect of modification (process):  cell motility, inhibited
Comments:  Akt induces Rac1 degradation via S71 phosphorylation